XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net loss $ (11,870) $ (4,581)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 774 57
Common stock issued for services 315 639
Change in fair value of contingent consideration liabilities 3,690 0
Compensation expense related to grant of stock options 303 176
Amortization of operating lease right of use asset 15 0
Amortization of debt discount 0 27
(Increase) decrease in:    
Accounts receivable (2,236) (689)
Prepaid expenses and other current assets (1,020) 90
Inventory (8,304) (1,012)
Increase in:    
Accounts payable 2,255 62
Accrued expenses 194 37
Sales tax payable 5 (19)
Deferred revenue 155 52
Net cash used in operating activities (15,724) (5,161)
Investing Activities:    
Working capital payment for acquisition (811) 0
Purchases of equipment (755) (473)
Funding of patent costs (79) (61)
Net cash used in investing activities (1,645) (534)
Financing Activities:    
Taxes paid related to net share settlement of equity awards 0 (614)
Proceeds from warrant exercises 318 2,684
Payments of equity offering costs (218) 0
Net cash provided by financing activities 100 2,070
Net decrease in cash (17,269) (3,625)
Cash at beginning of period 21,949 26,703
Cash at end of period 4,680 23,078
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Fair value of common stock issued as consideration for business combination 14,359 0
Purchase of property and equipment by incurring current liabilities 9 0
Depreciation cost capitalized into inventory 126 22
Right-of-use assets obtained in exchange for lease liabilities 192 0
Issuance of stock for Committed Equity Line $ 140 $ 0